Who makes Ingrezza Pill?

Ingrezza Pill is developed by The Orthopedic Foundation.

What development phase is Ingrezza Pill in?

Ingrezza Pill is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Ingrezza Pill

The Orthopedic Foundation · FDA-approved active Small molecule Quality 1/100

At a glance

Generic name	Ingrezza Pill
Sponsor	The Orthopedic Foundation
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Valbenazine in Obsessive Compulsive Disorder (PHASE2)
Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ingrezza Pill CI brief — competitive landscape report
Ingrezza Pill updates RSS · CI watch RSS
The Orthopedic Foundation portfolio CI